Predictors of Response to Direct Acting Anti-Viral Therapy in Patients With Decompensated Hepatitis C Cirrhosis

被引：0
|
作者：
Debnath, Prasanta, II
Chandnani, Sanjay
Rathi, Pravin
Nair, Sujit
Udgirkar, Suhas
机构：
[1] Topiwalla Natl Med Coll, Mumbai, Maharashtra, India
[2] BYL Nair Charitable Hosp, Mumbai, Maharashtra, India
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2019年 / 114卷
关键词：
D O I：
10.14309/01.ajg.0000593444.12705.94
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
977
引用
收藏
页码：S568 / S568
页数：1
相关论文
共 50 条
  • [1] Viral response guided therapy for hepatitis C in the approaching era of direct acting anti-viral agents
    Berzsenyi, Mark D.
    Roberts, Stuart K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (04) : 655 - 656
  • [2] Indicators and predictors of response to anti-viral therapy in chronic hepatitis C
    Lee, SS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (05) : 611 - 621
  • [3] The association between hepatocellular carcinoma and direct-acting anti-viral treatment in patients with decompensated cirrhosis
    Mecci, Ali Jibran
    Kemos, Polychronis
    Leen, Clifford
    Lawson, Adam
    Richardson, Paul
    Khakoo, Salim I.
    Agarwal, Kosh
    Mutimer, David
    Rosenberg, William M.
    Foster, Graham R.
    Irving, William L.
    Agarwal, K.
    Aldersley, M.
    Ali, A.
    Aravamuthan, S.
    Aspinall, R.
    Barnes, E.
    Brown, A.
    Ch'ng, C.
    Corless, L.
    Cramp, M.
    Foster, G. R.
    Foxton, M.
    Gorard, D.
    Gordon, F.
    Lawson, A.
    Leen, C.
    Moreea, S.
    Mutimer, D.
    Richardson, P.
    Rosenberg, W. R.
    Ryder, S. D.
    Stone, B.
    Ustianowski, A.
    Verma, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (02) : 204 - 214
  • [4] AN IMPORTANT NUANCE IN DIRECT ACTING ANTI-VIRAL HEPATITIS C THERAPY: GLYCEMIC CONTROL
    Ulteig, Crista
    Huq, Nadia
    Divan, Vidita
    Pedersen, Rachel
    Browne, Veron
    GASTROENTEROLOGY, 2018, 154 (06) : S1203 - S1203
  • [5] Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
    Foster, Graham R.
    Irving, William L.
    Cheung, Michelle C. M.
    Walker, Alex J.
    Hudson, Benjamin E.
    Verma, Suman
    McLauchlan, John
    Mutimer, David J.
    Brown, Ashley
    Gelson, William T. H.
    MacDonald, Douglas C.
    Agarwal, Kosh
    JOURNAL OF HEPATOLOGY, 2016, 64 (06) : 1224 - 1231
  • [6] Era of direct acting anti-viral agents for the treatment of hepatitis C
    Monjur Ahmed
    World Journal of Hepatology, 2018, (10) : 670 - 684
  • [7] Editorial: hepatitis C direct acting anti-viral agents and the kidney
    Hussaini, T.
    Yoshida, E. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (03) : 378 - 379
  • [8] Era of direct acting anti-viral agents for the treatment of hepatitis C
    Ahmed, Monjur
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (10) : 670 - 684
  • [9] Tacrolimus Levels after Direct Acting Anti-Viral Therapy in Hepatitis C Heart Transplantation
    Morris, K. L.
    Adlam, J. P.
    Haleem, A.
    Patel, A.
    Garcia-Cortes, R.
    Chaudhry, S.
    Proctor, J.
    Zanotti, G.
    Walsh, M. N.
    Salerno, C.
    Bochan, M.
    Ravichandran, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S168 - S168
  • [10] Direct-Acting Antiviral Therapy for Patients with Chronic Hepatitis C Infection and Decompensated Cirrhosis
    Pearlman, Brian L.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (05) : 1551 - 1561
12345